Abstract Details

Title Using Nature's Collaterals: Contralateral Access for Application of Tissue Plasminogen Activator in the Setting of Acute Ischemic Stroke

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 018

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Theresa Williamson	No disclosure on file
Joseph L. Schindler, MD (Yale University Department of Neurology)	Dr. Schindler has received personal compensation for serving as an employee of Aeromics. Dr. Schindler has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Aeromics. Dr. Schindler has received stock or an ownership interest from Aeromics. Dr. Schindler has received publishing royalties from a publication relating to health care.
	No disclosure on file
Alberto Ascherio, MD, PhD	Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .

��ɫ��